FindTrial
Sign In

Barriers to Eye Screening for people with Diabetes in India

To understand the barriers and facilitators of Diabetic Retinopathy screening & follow-up: An exploratory study from India and Thailand

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/04/024695
Enrollment
500
Registered
2020-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z048- Encounter for examination and observation for other specified reasons Health Condition 2: E113- Type 2 diabetes mellitus with ophthalmic complications

Interventions

Intervention1: Development of potential Interventional strategies: Phase 1: Formative phase using qualitative methods Phase 2: Implementation and testing of intervention Intervention2: NIL : NIL

Sponsors

Lions Club International Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adults who are > 40 years of age Ability to give informed consent Local residents of Indian origin

Exclusion criteria

Exclusion criteria: Retinal pathology other than DR Subjects who do not have the ability to give consent Vulnerable adults in whom it may not be possible to carry out all tests

Design outcomes

Primary

MeasureTime frame
To understand the barriers and facilitators for compliance to DR screening and follow upTimepoint: The screening is aimed to be completed in 18 to 36 months.—

Secondary

MeasureTime frame
To plan potential intervention strategiesTimepoint: The screening is aimed to be completed in 18 to 36 months.—

Countries

India

Contacts

Public ContactDr Rajiv Raman

Sankara Nethralaya

rajivpgraman@gmail.com9444288708

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026